105 related articles for article (PubMed ID: 10327155)
1. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice.
Nagano S; Ogawa Y; Yanagihara T; Sakoda S
Neurosci Lett; 1999 Apr; 265(3):159-62. PubMed ID: 10327155
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice.
Nagano S; Fujii Y; Yamamoto T; Taniyama M; Fukada K; Yanagihara T; Sakoda S
Exp Neurol; 2003 Feb; 179(2):176-80. PubMed ID: 12618124
[TBL] [Abstract][Full Text] [Related]
3. Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Exp Neurol; 2008 Sep; 213(1):122-8. PubMed ID: 18617166
[TBL] [Abstract][Full Text] [Related]
4. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Hottinger AF; Fine EG; Gurney ME; Zurn AD; Aebischer P
Eur J Neurosci; 1997 Jul; 9(7):1548-51. PubMed ID: 9240414
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
6. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
Tokuda E; Okawa E; Watanabe S; Ono S; Marklund SL
Neurobiol Dis; 2013 Jun; 54():308-19. PubMed ID: 23321002
[TBL] [Abstract][Full Text] [Related]
9. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
[TBL] [Abstract][Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
11. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis.
Tokuda E; Okawa E; Ono S
J Neurochem; 2009 Oct; 111(1):181-91. PubMed ID: 19656261
[TBL] [Abstract][Full Text] [Related]
14. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
15. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
[TBL] [Abstract][Full Text] [Related]
16. Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Tokuda E; Furukawa Y
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136532
[TBL] [Abstract][Full Text] [Related]
17. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.
Li M; Ona VO; Guégan C; Chen M; Jackson-Lewis V; Andrews LJ; Olszewski AJ; Stieg PE; Lee JP; Przedborski S; Friedlander RM
Science; 2000 Apr; 288(5464):335-9. PubMed ID: 10764647
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
19. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
